SCHEMBL4902485

SCHEMBL4902485

CCN(c1csc(-c2ccc(F)cc2)n1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.40
MAPT P10636 4/20 0.40
RXFP1 Q9HBX9 1/20 0.38
NPC1 O15118 1/20 0.38
CASP3 P42574 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
LMNA P02545 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TSHR P16473 1/20 0.36
TRPM8 Q7Z2W7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907283 0.93 TP53 (0.42) TP53MAPTNPC1RAB9ALMNA
SCHEMBL4902584 0.90 MAPT (0.43) TP53MAPTRXFP1NPC1CASP3
SCHEMBL4904978 0.90 LMNA (0.41) TP53MAPTLMNAALDH1A1TSHR
SCHEMBL4904959 0.89 MAPT (0.39) TP53MAPTNPC1RAB9APSEN1
SCHEMBL4900904 0.89 NR1I2 (0.36) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL4898066 0.89 ALDH1A1 (0.39) TP53MAPTLMNAALDH1A1TSHR
SCHEMBL4900527 0.86 MAPT (0.41) TP53MAPTRXFP1NPC1CASP3
SCHEMBL4895425 0.85 TRPM8 (0.39) TP53MAPTNPC1CASP3RAB9A
SCHEMBL4902470 0.82 TP53 (0.43) TP53MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL4906743 0.82 ALDH1A1 (0.44) TP53MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TP53 3260/4885MAPT 1858/4885RXFP1 3136/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TP53 3421/4885MAPT 1786/4885RXFP1 2846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.